Iodixanol Injectable Solution bulk supplier for pharma manufacturers

Iodixanol Injectable Solution Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 270 mg/mL, 320 mg/mL, 370 mg/mL

Reference Brands: Visipaque(US & EU)

Iodixanol is a contrast agent that enhances imaging by increasing radiopacity in X-ray and CT scans. It provides clear visualization of blood vessels, organs, and tissues, supporting accurate diagnosis. Benefits include high-quality imaging, rapid excretion, safety, and improved diagnostic precision, aiding effective healthcare worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Iodixanol, marketed as Visipaque, is approved in the US by the FDA and in the EU via EMA for use as a contrast agent in X-ray and CT imaging procedures. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Supporting regional adherence supports swift approval, safe administration, and global availability of iodixanol, facilitating effective diagnostics worldwide.

Iodixanol Injectable Solution — third party manufacturing & bulk supply

Iodixanol Injectable Solution is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Iodixanol Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Iodixanol Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Iodixanol Injectable Solution →

Back to Listing

Frequently Asked Questions

Iodixanol Injectable Solution is listed as Injectable Solution in 270 mg/mL, 320 mg/mL, 370 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Iodixanol Injectable Solution is referenced against Visipaque(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.